Peter van Mourik

176 Chapter 8 18. Marozkina, N. V et al. Hsp 70/Hsp 90 organizing protein as a nitrosylation target in cystic fibrosis therapy. Proc. Natl. Acad. Sci. U. S. A. 107 , 11393–8 (2010). 19. Sigoillot, M. et al. Domain-interface dynamics of CFTR revealed by stabilizing nanobodies. Nat. Commun. 10 , (2019). 20. Sato, T. & Clevers, H. Growing self-organizing mini-guts from a single intestinal stem cell: mechanism and applications. Science 340 , 1190–4 (2013). 21. Clevers, H. Modeling Development and Disease with Organoids. Cell 165 , 1586–1597 (2016). 22. Dekkers, J. F. et al. A functional CFTR assay using primary cystic fibrosis intestinal organoids. Nat. Med. 19 , 939–45 (2013). 23. de Winter-de Groot, K. M. et al. Stratifying infants with cystic fibrosis for disease severity using intestinal organoid swelling as a biomarker of CFTR function. Eur. Respir. J. 52 , 1702529 (2018). 24. de Winter – de Groot, K. M. et al. Forskolin-induced swelling of intestinal organoids correlates with disease severity in adults with cystic fibrosis and homozygous F508del mutations. J. Cyst. Fibros. 1–6 (2019) doi:10.1016/j. jcf.2019.10.022. 25. Zomer-van Ommen, D. D. et al. Comparison of ex vivo and in vitro intestinal cystic fibrosis models to measure CFTR-dependent ion channel activity. J. Cyst. Fibros. 17 , 316–324 (2018). 26. Dekkers, J. F. et al. Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis. Sci. Transl. Med. 8 , 344ra84 (2016). 27. Berkers, G. et al. Rectal Organoids Enable Personalized Treatment of Cystic Fibrosis. Cell Rep. 26 , 1701-1708.e3 (2019). 28. Zomer-van Ommen, D. D. et al. Limited premature termination codon suppression by read-through agents in cystic fibrosis intestinal organoids. J. Cyst. Fibros. 15 , 158–62 (2016). 29. HIT-CF Europe. https://www.hitcf.org/. 30. De Boeck, K. et al. Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation. J. Cyst. Fibros. 13 , 674–680 (2014). 31. Friedmacher, F. & Puri, P. Rectal suction biopsy for the diagnosis of Hirschsprung’s disease: a systematic review of diagnostic accuracy and complications. Pediatr. Surg. Int. 31 , 821–30 (2015). 32. Servidoni, M. F. et al. Rectal forceps biopsy procedure in cystic fibrosis: technical aspects and patients perspective for clinical trials feasibility. BMC Gastroenterol. 13 , 91 (2013). 33. Vonk, A. M. et al. Protocol for Application , Standardization and Validation of the Forskolin-Induced Swelling Assay in Cystic Fibrosis Human Colon Organoids Protocol for Application , Standardization and Validation of the Forskolin-Induced Swelling Assay in Cystic Fibrosis. STAR Protoc. 100019 (2020) doi:10.1016/j. xpro.2020.100019. 34. Boj, S. F. et al. Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients. J. Vis. Exp. 1–12 (2017) doi:10.3791/55159.